Servier Canada inaugurates centre of excellence in clinical research

Montréal, October 10, 2014 – Servier Research Group, the second largest French pharmaceutical company, announces the inauguration of a centre of excellence in clinical research in Greater Montréal, to be operated by its subsidiary, Servier Canada. Located in the heart of Laval’s Cité de la Biotech, the new complex is the result of more than $17 million in investments. The 30,000 square-foot centre performs research in cardiovascular disease, cancer and neuropsychiatry.

“Our new clinical research centre and the Fonds de recherche Tremblay Servier, which we are inaugurating today, embody our commitment to make the best possible therapeutic solutions available to Canada’s medical professionals and their patients. Greater Montréal is an ideal location to advance therapeutic innovation,” noted Olivier Laureau, President of Servier Group.


The event was attended by Francine Charbonneau, Minister of Families and responsible for the Laval region and Marc Demers, Mayor of Laval.

This new complex is part of a larger project that includes the construction of a brand new building and a full renovation of the existing structures. The complex features a 150-seat auditorium that will be used for scientific events and medical training. Equipped with the latest technologies enabling communication and collaboration among researchers all over the world, this facility will house the Canadian International Centre for Therapeutic Research (ICTR) and the Servier Canada National Centre for Professional Training.

“We are very proud to inaugurate our new centre of excellence in clinical research in a metropolis that is recognized for the quality of its research and capacity for innovation,” said Frédéric Fasano, Chief Executive Officer of Servier Canada. “Over the past five years, we have invested more than $100 million in research and development in Canada and this new $17 million-plus investment certainly speaks to the important role of research in our growth model,” he added.

Servier Canada recognizes the added value of collaboration and joint action by all research sector stakeholders including university research centres as well as pharmaceutical and biotechnology companies. Servier Canada is currently involved in several innovation development projects with partners such as the Montréal Heart Institute, INRS (cardiology), McGill University (cardiology) and Université de Montréal (chemistry, cardiology, metabolism and neurology).

Montréal International, in collaboration with LAVAL TECHNOPOLE, the Biotech City and Montréal InVivo, provided support to Servier Canada to expand its activities. “With this new centre of excellence, Servier Canada consolidates Greater Montréal’s position as Canada’s premier laboratory research venue. By investing here, Servier Canada can benefit from a biopharmaceutical environment that fosters innovation by bringing together high-level scientific expertise,” explained Dominique Anglade, President and CEO of Montréal International. “With more than 600 establishments working in the health and pharmaceutical sectors, Greater Montréal is home to leaders and researchers who originate the ideas, treatments and medical technologies of tomorrow.”

Employing 45,000 people, Greater Montréal’s Life Sciences and Health Technologies cluster ranks sixth among North American cities in terms of number of jobs. The sector is comprised of 600 establishments, including 300 publics and parapublic facilities, that employ a total of 12,000 researchers and professionals.

About Servier Group (

Founded in France in 1954 by Dr. Jacques Servier, Servier Research Group is an independent pharmaceutical group, with more than 22,000 employees, including 3,000 in R&D, around the world and is present in over 140 countries. Servier Canada, created in 1978, is at present the Group’s 4th international subsidiary. It employs 325 people, including 161 in Québec, and invested 14.5% of its revenues in research and development in 2013.

About Montréal International (

Created in 1996, Montréal International is the result of a private-public partnership. Its mission is to act as an economic driver for Greater Montréal to attract foreign wealth while accelerating the success of its partners and clients. Its mandates include attracting foreign direct investments, international organizations and international strategic workers as well as promoting the competitive and international environment of Greater Montréal. Montréal International, a non-profit organization, is funded by the private sector, the governments of Canada and Québec, the Communauté métropolitaine de Montréal (Montréal Metropolitan Community) and the City of Montréal.

Leave a Reply